Reply to T. Kurokawa et al

J Clin Oncol. 2018 Aug 10;36(23):2454. doi: 10.1200/JCO.2018.79.0832. Epub 2018 Jun 29.

Authors

Shveta S Motwani¹, Gary C Curhan¹

Affiliation

¹ Shveta S. Motwani, Brigham and Women's Hospital; Dana-Farber Cancer Institute; and Harvard Medical School, Boston, MA; and Gary C. Curhan, Brigham and Women's Hospital; Channing Division of Network Medicine; and Harvard Medical School, Boston, MA.

PMID: 29958038
DOI: 10.1200/JCO.2018.79.0832

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Comment

MeSH terms

Acute Kidney Injury*
Cisplatin*
Humans

Substances

Cisplatin

Grants and funding